One of the out-patient rehab options for people in Inglewood battling with opioid abuse and addiction is opioid maintenance therapy. Licensed centers and doctors are authorized to give certain medications to opioid dependent clients, many that are opioid-based also and are addictive. In low doses the individual does not feel high and also doesn't have acute cravings and is not in opioid withdrawal. Methadone is the first med used for this sole purpose, but there are alternative options to select from.
Methadone is an opioid and is meant to be taken at an outpatient medical center licensed to administer the drug, which is taken daily in liquid or pill form. The price of the drug is around $150 monthly. Buprenorphine is also an opioid based med, and is in pill form often taken one day on, one day off. But different from Methadone that can only be administered in highly structured medical centers, Buprenorphine can be prescribed and administered in doctor's offices. The monthly cost of buprenorphine is about $300 per month for the generic version of the drug. There is also a version of buprenorphine that contains naloxone, which is a med that reverses the effects of opioids. An individual taking this formulation, also known as Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and costs around $450 per month. Naltrexone is another medication used in opioid maintenance therapy, but unlike the other medications aforementioned it is an opioid blocker and is not an opioid. A person has the choice to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, the drug prevents an individual from experience being high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 monthly.
There are 2 Alcohol and Drug Rehabilitation Centers offering this service in Inglewood, CA
For All Drug and Alcohol Treatment Programs In Inglewood, Click Here.